Sensor Therapeutics
Developer of a wearable rehabilitation platform that combines surface electromyography, bioimpedance and motion sensing with a mobile app and cloud services to provide real-time biofeedback and remote monitoring for post-operative soft-tissue rehabilitation. Completed proof-of-concept and early clinical evaluation, received SBIR funding for commercialization, and plans product releases for rotator cuff and ACL rehabilitation.
Industries
Nr. of Employees
small (1-50)
Sensor Therapeutics
Products
MyoGuard System
A wearable rehabilitation system comprising a wearable pod and patch with sensors for EMG, bioimpedance and limb angle, a mobile application for real-time recording and feedback, and a cloud platform for data storage and clinician presentation.
MyoGuard System
A wearable rehabilitation system comprising a wearable pod and patch with sensors for EMG, bioimpedance and limb angle, a mobile application for real-time recording and feedback, and a cloud platform for data storage and clinician presentation.
Services
Mobile- and cloud-enabled service providing patient biofeedback, activity recording, and clinician access to adherence and progress data to support post-operative rehabilitation.
Mobile- and cloud-enabled service providing patient biofeedback, activity recording, and clinician access to adherence and progress data to support post-operative rehabilitation.
Expertise Areas
- Wearable medical device development
- Rehabilitation technology
- Surface electromyography (sEMG) applications
- Remote patient monitoring
Key Technologies
- Surface electromyography (sEMG)
- Bioimpedance sensing
- Inertial/motion sensing (angle measurement)
- Wearable electronics and sensor integration
News & Updates
Conducted an NIH SBIR Phase I funded clinical study and completed a proof-of-concept demonstrating device performance comparable to standard of care.
Received a Phase II SBIR award of $1.9M to support product commercialization.
Announced plan to release the rehabilitation system for rotator cuff repair before the end of 2026 and to adapt the platform for ACL rehabilitation in 2026.
Conducted an NIH SBIR Phase I funded clinical study and completed a proof-of-concept demonstrating device performance comparable to standard of care.
Received a Phase II SBIR award of $1.9M to support product commercialization.
Announced plan to release the rehabilitation system for rotator cuff repair before the end of 2026 and to adapt the platform for ACL rehabilitation in 2026.